Osteolysis
9
0
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
Incidence & Clinical Significance of Osteolysis Following PEEK Suture Anchor Use in Hand & Wrist Surgery
Regular Home-use Dual Light Photodynamic Therapy in the Prevention of Osteolysis After Dental Implant Surgery
Bio-Integrative Versus Metallic Screws for Calcaneus Osteotomies
Denosumab for Treating Periprosthetic Osteolysis.
Post-Market Study of the Modular Revision Hip System
Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements
Study to Investigate Adherence of Patients to Clodronate (Bonefos) Treatment
CT for Diagnosis of Implant Stability in Revision Arthroplasty